Latest Share Purchase Plan News

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Calix Limited has extended its Share Purchase Plan closing date to January 31, 2025, offering eligible shareholders more time to invest up to $30,000 each. The company may close the plan early if subscriptions exceed $5 million, signaling strong investor interest in its decarbonisation technology.

True North Copper has successfully completed a $53.44 million capital raising and debt restructuring, exiting voluntary administration and securing ASX reinstatement. The company shifts focus to exploration at Mt Oxide and Cloncurry, retracting prior production plans for the next 12 months.